Ultrastructural changes in bacterial membranes induced by nano-assemblies β-cyclodextrin chlorhexidine: SEM, AFM, and TEM evaluation

References

• Davis ME, Brewster ME. Cyclodextrin-based pharmaceutics: past, present and future. Nat Rev Drug Discov 2004;3:1023–1035.
   PubMed Web of Science ®Google Scholar
• Brittain H G. Excipient development for pharmaceutical, biotechnology and drug delivery systems. Pharm Dev Technol 2007;12:109–110.
   Google Scholar
• Loftsson T, Vogensen SB, Brewster ME, Konrádsdóttir F. Effects of cyclodextrins on drug delivery through biological membranes. J Pharm Sci 2007;96:2532–2546.
   PubMed Web of Science ®Google Scholar
• Lan D, Zhang HY, Pang BS. [Effect of guishen zhiyang recipe for treatment of patients with senile pruritus of blood-deficiency and Gan-hyperactive syndrome type and its impact on stem cell factor and dynorphin]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2009;29:611–613.
   PubMedGoogle Scholar
• Komljenovic I, Marquardt D, Harroun TA, Sternin E. Location of chlorhexidine in DMPC model membranes: a neutron diffraction study. Chem Phys Lipids 2010;163:480–487.
   PubMed Web of Science ®Google Scholar
• Ellepola AN, Samaranayake LP. Adjunctive use of chlorhexidine in oral candidoses: a review. Oral Dis 2001;7:11–17.
   PubMed Web of Science ®Google Scholar
• Hidalgo E, Dominguez C. Mechanisms underlying chlorhexidine-induced cytotoxicity. Toxicol In Vitro 2001;15:271–276.
   PubMed Web of Science ®Google Scholar
• Lima KC, Neves AA, Beiruth JB, Magalhães FAC, Uzeda M. Levels of infection and colonization of some oral bacteria after use of naf, chlorhexidine and a combined chlorhexidine with naf mouthrinses. Braz J Microbiol 2001;32:158–161.
   Web of Science ®Google Scholar
• Faria G, Cardoso CR, Larson RE, Silva JS, Rossi MA. Chlorhexidine-induced apoptosis or necrosis in L929 fibroblasts: a role for endoplasmic reticulum stress. Toxicol Appl Pharmacol 2009;234:256–265.
   PubMed Web of Science ®Google Scholar
• Gianelli M, Chellini F, Margheri M, Tonelli P, Tani A. Effect of chlorhexidine digluconate on different cell types: a molecular and ultra structural investigation. Toxicol In vitro 2008;22:308–317.
   PubMed Web of Science ®Google Scholar
• Cortés ME, Sinisterra RD, Ávila-Campos MJ, Tortamano N, Rocha RG. The chlorhexidine:β-cyclodextrin inclusion compound: preparation, characterization and microbiological evaluation. J Inclusion Phen Macrocyclic Chem 2001;40:297–302.
   Web of Science ®Google Scholar
• Raso EMG, Cortes ME, Teixeira KI, Franco MB, Mohallem NDS, Sinisterra R D. A new controlled release system of chlorhexidine and chlorhexidine:β-cd inclusion compounds based on porous silica. J Inclusion Phen Macrocyclic Chem 2010;67:159–168.
   Web of Science ®Google Scholar
• Denadai AM, Teixeira KI, Santoro MM, Pimenta AM, Cortés ME, Sinisterra RD. Supramolecular self-assembly of β-cyclodextrin: an effective carrier of the antimicrobial agent chlorhexidine. Carbohydr Res 2007;342:2286–2296.
   PubMed Web of Science ®Google Scholar
• Thatiparti TR, Shoffstall AJ, von Recum HA. Cyclodextrin-based device coatings for affinity-based release of antibiotics. Biomaterials 2010;31:2335–2347.
   PubMed Web of Science ®Google Scholar
• Irie T, Fukunaga K, Pitha J. Hydroxypropylcyclodextrins in parenteral use. I: lipid dissolution and effects on lipid transfers in vitro. J Pharm Sci 1992;81:521–523.
   PubMed Web of Science ®Google Scholar
• Mileykovskaya E, Dowhan W. Visualization of phospholipid domains in Escherichia coli by using the cardiolipin-specific fluorescent dye 10-N-nonyl acridine orange. J Bacteriol 2000;182:1172–1175.
   PubMed Web of Science ®Google Scholar
• da Silva A Jr, Teschke O. Effects of the antimicrobial peptide PGLa on live Escherichia coli. Biochim Biophys Acta 2003;1643:95–103.
   PubMed Web of Science ®Google Scholar
• Jiang P, Yan PK, Chen JX, Zhu BY, Lei XY, Yin WD et al. High density lipoprotein 3 inhibits oxidized low density lipoprotein-induced apoptosis via promoting cholesterol efflux in RAW264.7 cells. Acta Pharmacol Sin 2006;27:151–157.
   PubMed Web of Science ®Google Scholar
• Li A, Lee PY, Ho B, Ding JL, Lim CT. Atomic force microscopy study of the antimicrobial action of Sushi peptides on Gram negative bacteria. Biochim Biophys Acta 2007;1768:411–418.
   PubMed Web of Science ®Google Scholar
• Li P, Wohland T, Ho B, Ding JL. Perturbation of Lipopolysaccharide (LPS) Micelles by Sushi 3 (S3) antimicrobial peptide. The importance of an intermolecular disulfide bond in S3 dimer for binding, disruption, and neutralization of LPS. J Biol Chem 2004;279:50150–50156.
   PubMed Web of Science ®Google Scholar
• Slots J, Ting M. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment. Periodontol 2000 1999;20:82–121.
   PubMed Web of Science ®Google Scholar
• Olsen I, Shah HN, Gharbia SE. Taxonomy and biochemical characteristics of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Periodontol 2000 1999;20:14–52.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Burmeister L, Bartlett MS, Rinaldi MG. Multicenter evaluation of four methods of yeast inoculum preparation. J Clin Microbiol 1988;26:1437–1441.
   PubMed Web of Science ®Google Scholar
• Ruan S, Young E, Luce MJ, Reiser J, Kolls JK, Shellito JE. Conditional expression of interferon-gamma to enhance host responses to pulmonary bacterial infection. Pulm Pharmacol Ther 2006;19:251–257.
   PubMed Web of Science ®Google Scholar
• Helander IM, Nurmiaho-Lassila EL, Ahvenainen R, Rhoades J, Roller S. Chitosan disrupts the barrier properties of the outer membrane of gram-negative bacteria. Int J Food Microbiol 2001;71:235–244.
   PubMed Web of Science ®Google Scholar
• López-Expósito I, Amigo L, Recio I. Identification of the initial binding sites of αs2-casein f(183–207) and effect on bacterial membranes and cell morphology. Biochim Biophys Acta 2008;1778:2444–2449.
   PubMed Web of Science ®Google Scholar
• Chwalibog A, Sawosz E, Hotowy A, Szeliga J, Mitura S, Mitura K et al. Visualization of interaction between inorganic nanoparticles and bacteria or fungi. Int J Nanomedicine 2010;5:1085–1094.
   PubMed Web of Science ®Google Scholar
• Kirmizis D, Logothetidis S. Atomic force microscopy probing in the measurement of cell mechanics. Int J Nanomedicine 2010;5:137–145.
   PubMed Web of Science ®Google Scholar
• Deupree SM, Schoenfisch MH. Morphological analysis of the antimicrobial action of nitric oxide on gram-negative pathogens using atomic force microscopy. Acta Biomater 2009;5:1405–1415.
   PubMed Web of Science ®Google Scholar
• Vandepitte J, Engback K, Piot P, Heuck CC. (1991). Basic microbiology procedures in clinical bacteriology. Geneva:World Health Organization;85.
   Google Scholar
• Gaboriaud F, Dufrêne YF. Atomic force microscopy of microbial cells: application to nanomechanical properties, surface forces and molecular recognition forces. Colloids Surf B Biointerfaces 2007;54:10–19.
   PubMed Web of Science ®Google Scholar
• Kolenbrander PE, Egland PG, Diaz PI,Palmer RJ. Genome–genome interactions: bacterial communities in initial dental plaque. TRENDS in Microbiol 2005;13:11–5.
   PubMed Web of Science ®Google Scholar
• Li XF, Feng XQ, Yang S, Fu GQ, Wang TP, Su ZX. Chitosan kills Escherichia coli through damage to be of cell membrane mechanism. Carbohydrate Polym 2010;79:493–499.
   Web of Science ®Google Scholar
• Johansen C, Gill T, Gram L. Changes in cell morphology of Listeria monocytogenes and Shewanella putrefaciens resulting from the action of protamine. Appl Environ Microbiol 1996;62:1058–1064.
   PubMed Web of Science ®Google Scholar
• Dennison SR, Morton LH, Harris F, Phoenix DA. The impact of membrane lipid composition on antimicrobial function of an α-helical peptide. Chem Phys Lipids 2008;151:92–102.
   PubMed Web of Science ®Google Scholar
• Shaw JE, Epand RF, Hsu JC, Mo GC, Epand RM, Yip CM. Cationic peptide-induced remodelling of model membranes: direct visualization by in situ atomic force microscopy. J Struct Biol 2008;162:121–138.
   PubMed Web of Science ®Google Scholar